XPONANCE, INC. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 278 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2022. The put-call ratio across all filers is 0.78 and the average weighting 0.2%.

Quarter-by-quarter ownership
XPONANCE, INC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2024$427,925
-13.5%
16,465
-4.8%
0.00%
-20.0%
Q1 2024$494,494
+7.1%
17,290
+14.6%
0.01%
-16.7%
Q4 2023$461,815
+13.6%
15,092
-0.2%
0.01%0.0%
Q3 2023$406,516
-25.8%
15,129
-1.5%
0.01%
-14.3%
Q2 2023$547,559
+30.2%
15,355
-7.3%
0.01%
+16.7%
Q1 2023$420,573
-36.4%
16,558
+1.6%
0.01%
-45.5%
Q4 2022$660,925
+22.6%
16,295
-0.1%
0.01%
+10.0%
Q3 2022$539,000
-6.1%
16,308
+0.1%
0.01%
-16.7%
Q2 2022$574,000
-18.9%
16,293
+5.8%
0.01%0.0%
Q1 2022$708,000
-30.3%
15,396
+0.4%
0.01%
-25.0%
Q4 2021$1,016,000
+4.3%
15,329
-1.8%
0.02%
-11.1%
Q3 2021$974,000
-27.6%
15,603
-4.0%
0.02%
-28.0%
Q2 2021$1,345,000
+78.6%
16,246
+43.0%
0.02%
+56.2%
Q1 2021$753,000
-27.8%
11,363
-16.4%
0.02%
-30.4%
Q4 2020$1,043,000
+78.9%
13,587
+0.4%
0.02%
+64.3%
Q3 2020$583,000
-2.2%
13,529
-1.9%
0.01%
-6.7%
Q2 2020$596,00013,7970.02%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q3 2022
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders